Huo G - Search Results

1

Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.

Huo G, Song Y, Chen P. Huo G, et al. J Gynecol Oncol. 2024 Nov;35(6):e86. doi: 10.3802/jgo.2024.35.e86. Epub 2024 Apr 8. J Gynecol Oncol. 2024. PMID: 38606826 Free PMC article.

2

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis.

Zhang Q, Huo GW, Zhang HZ, Song Y. Zhang Q, et al. Open Med (Wars). 2020 Jun 10;15(1):447-456. doi: 10.1515/med-2020-0110. eCollection 2020. Open Med (Wars). 2020. PMID: 33313405 Free PMC article.

3

Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis.

Huo GW, Zuo R, Song Y, Chen WD, Chen WM, Chong DQ, Zhang HM, Jia SS, Chen P. Huo GW, et al. Open Med (Wars). 2021 May 11;16(1):728-736. doi: 10.1515/med-2021-0272. eCollection 2021. Open Med (Wars). 2021. PMID: 34013044 Free PMC article.

4

A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors.

Huo G, Wang Y, Chen J, Song Y, Zhang C, Guo H, Zuo R, Zhu F, Cui J, Chen W, Chen W, Chen P. Huo G, et al. Front Oncol. 2021 May 25;11:692136. doi: 10.3389/fonc.2021.692136. eCollection 2021. Front Oncol. 2021. PMID: 34113576 Free PMC article.

5

The incidence of gastrointestinal adverse events in patients with advanced non-small cell lung cancer (NSCLC) treated with PD-1 inhibitors: a meta-analysis.

Huo GW, Zhu FY, Zuo R, Song Y, Chen WD, Chen WM, Zhang HM, Jia SS, Chen P. Huo GW, et al. Transl Cancer Res. 2021 Jul;10(7):3389-3403. doi: 10.21037/tcr-21-125. Transl Cancer Res. 2021. PMID: 35116644 Free PMC article.

6

Inhibitors of PD-1 in Non-Small Cell Lung Cancer: A Meta-Analysis of Clinical and Molecular Features.

Huo G, Liu W, Chen P. Huo G, et al. Front Immunol. 2022 Apr 5;13:875093. doi: 10.3389/fimmu.2022.875093. eCollection 2022. Front Immunol. 2022. PMID: 35479081 Free PMC article.

7

Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis.

Liu W, Huo G, Chen P. Liu W, et al. Among authors: huo g. Front Immunol. 2022 Jun 21;13:909027. doi: 10.3389/fimmu.2022.909027. eCollection 2022. Front Immunol. 2022. PMID: 35799785 Free PMC article.

8

Oncogenic role of TWF2 in human tumors: A pan-cancer analysis.

Liu W, Huo G, Chen P. Liu W, et al. Among authors: huo g. Open Med (Wars). 2022 Sep 5;17(1):1425-1437. doi: 10.1515/med-2022-0547. eCollection 2022. Open Med (Wars). 2022. PMID: 36128444 Free PMC article.

9

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis.

Cai Q, Huo GW, Zhu FY, Yue P, Yuan DQ, Chen P. Cai Q, et al. Hum Vaccin Immunother. 2022 Dec 30;18(7):2145102. doi: 10.1080/21645515.2022.2145102. Epub 2022 Dec 5. Hum Vaccin Immunother. 2022. PMID: 36471629 Free PMC article.

10

High incidence and reversible bradycardia events following alectinib initiation.

Yuan D, Zhu F, Zuo R, Wang Y, Huo G, Cui J, Yue P, Chen P. Yuan D, et al. Among authors: huo g. Thorac Cancer. 2023 Feb;14(5):479-488. doi: 10.1111/1759-7714.14769. Epub 2022 Dec 19. Thorac Cancer. 2023. PMID: 36535917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters